August 5, 2024
From trauma medicine to revolutionized prosthetics and beyond, some of the most cutting-edge innovations in health and medicine have come from projects through the U.S. Department of Defense (DoD) and Department of Veterans Affairs. The Health of the Forces initiative, developed by Purdue University’s College of Health and Human Sciences (HHS) and Military Family Research Institute (MFRI) with support from the Purdue University Office of Research, aims to add to these innovations by providing Purdue faculty with the support needed to initiate their own life-changing discoveries that will serve military members, veterans and their families.
College of Health and Human Sciences advances Health of the Forces initiative through pilot grants
August 2, 2024
eversible protein phosphorylation is an abundant post-translational modification dynamically regulated by opposing kinases and phosphatases. Protein phosphorylation has been extensively studied in cell division, where waves of cyclin-dependent kinase activity, peaking in mitosis, drive the sequential stages of the cell cycle.
Inducible degradation-coupled phosphoproteomics identifies PP2A Rts1 as a novel eisosome regulator
August 1, 2024
The process of cellular senescence, a state of permanent cell cycle arrest, is a key area of longevity research due to the part it plays in both aging and cancer prevention. As cells age or encounter oncogenic stimuli, they cease dividing, thereby preventing the proliferation of potentially tumorigenic cells.
July 31, 2024
Purdue University’s second Antimicrobial Resistance Conference generated increased attendance this year, reflecting heightened interest in the event’s interdisciplinary approach to the topic that the World Health Organization (WHO) identifies as one of the top global public health and development threats. The conference featured distinguished keynote speakers and Purdue scholars from a variety of disciplines who shared the latest research findings and insights regarding the challenges posed by antibiotic resistance.
Purdue Draws Expanded Audience to Second Antimicrobial Resistance Conference
July 30, 2024
The prevalence of obesity worldwide has led to an increase in the risk of metabolic diseases and socio-economical burdens. Brown adipose tissue (BAT) has been established as a promising therapeutic target to overcome obesity, type 2 diabetes (T2D) and other metabolic syndromes.
July 26, 2024
Four medical and agbioscience researchers at Purdue University are receiving extra funding for their projects thanks to a grant from the Trask Innovation Fund.
July 25, 2024
Andrea Kasinski, Yoon Yeo and Jesse Chi Zhang have received support from the Trask Innovation Fund to further develop disease-fighting innovations for commercial use.
Cancer researchers awarded funds from Purdue Innovates to strengthen market readiness of their work
July 22, 2024
Anti-spoofing, ransomware and cyberattack-defense technology born in the Purdue University lab of Hany Abdel-Khalik, professor of nuclear engineering, has grown into an award-winning startup called Covert Defenses. The company, with offices in Lexington, Kentucky, and Knoxville, Tennessee, in addition to its West Lafayette headquarters, recently received first-place recognition at the Venture Club of Indiana’s Innovation Showcase competition, as did two other startups that originated at Purdue. The June competition featured 20 promising startup contenders, 240 entrepreneurs, investors, industry leaders and innovation enthusiasts.
Covert Defenses among three Purdue startups taking 1st place at Indianapolis Innovation Showcase
July 15, 2024
The intracellular bacterial pathogen Legionella pneumophila modulates host cell functions by secreting multiple effectors with diverse biochemical activities. In particular, effectors of the SidE family interfere with host protein ubiquitination in a process that involves production of phosphoribosyl ubiquitin (PR-Ub).
Legionella maintains host cell ubiquitin homeostasis by effectors with unique catalytic mechanisms
July 15, 2024
With four patents under his belt, Joshua Alexander, associate professor in Purdue University’s Department of Speech, Language, and Hearing Sciences, is no stranger to entrepreneurship and innovation. When he was approached about becoming the College of Health and Human Sciences’ (HHS) Innovation and Entrepreneurship Fellow, he was eager to give back to the college through the role, which began on July 1.
